Sleep Apnea, Obstructive
A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
Subtype terms (1)
More specific conditions that are subtypes of Sleep Apnea, Obstructive in the MeSH hierarchy.
- Obesity Hypoventilation Syndrome
2 drugs (1 approved, 1 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (61)
- melatonin
- hydrocodone
- montelukast
- propofol
- fluticasone
- methylprednisolone
- acetazolamide
- procaine benzylpenicillin
- paroxetine
- ketamine
- clavulanate
- mometasone
- prednisone
- ibuprofen
- sevoflurane
- leuprolide
- guanfacine
- amlodipine
- sodium oxybate
- xenon-129
- esketamine
- ketorolac
- nalbuphine
- nebivolol
- oxybutynin
- adalimumab
- valsartan
- acetaminophen
- donepezil
- progestin
- +31 more
Phase 3 trials (22)
Phase 2 trials (45)
- metformin
- allopurinol
- dalfampridine
- orlistat
- oxytocin
- ave0657
- bosentan
- mk-0249
- dimethyl fumarate
- colfosceril palmitate
- palmitoylethanolamide
- helium
- ketone
- lemborexant
- atorvastatin
- indomethacin
- caffeine
- propranolol
- celecoxib
- zonisamide
- palmitic acid
- losartan
- tiagabine
- oxygen
- quetiapine
- Sulthiame
- sinapultide
- aprepitant
- desipramine
- phosphatidylglycerol
- +15 more
Phase 1 trials (12)
Other trials (22)
- vitamin e
- acetylcysteine
- azelnidipine
- beetroot juice
- alprazolam
- progesterone
- liraglutide
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- levocarnitine
- metoclopramide
- vitamin c
- olmesartan
- rhodiola
- rocuronium
- sodium benzoate
- testosterone
- inactivated influenza vaccine
- menthol
- tramazoline hydrochloride
- lansoprazole
- vitamin a
- oxymetazoline
Organizations
Organization Involved with Phase 4 Indications (48)
- Abbott
- Jazz Pharmaceuticals
- Merck
- Wyeth
- GlaxoSmithKline
- Sunovion
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- United States Army
- Associação Fundo de Incentivo à Pesquisa
- Aarhus University
- University of Manitoba
- Chang Gung University
- Harvard University
- Emory University
- Federal University of Rio Grande do Sul
- Institut National de la Santé Et de la Recherche Médicale, France
- Katholieke Universiteit Leuven
- McGill University
- University of Lausanne
- University of Louisville
- University of Michigan
- University of South Florida
- University of Toronto
- University of Alberta
- University of Bologna
- University of Zurich
- Yonsei University
- Zagazig University
- +18 more
Organization Involved with Phase 3 Indications (22)
- Takeda
- Novo Nordisk
- Bioprojet
- Hamilton Health Sciences Corporation
- OSR Medical Inc.
- Clayton Sleep Insititute
- University of Pennsylvania
- Duke University
- Romaker & Associates
- University of Medicine and Dentistry of New Jersey
- University of Saskatchewan
- Chinese University of Hong Kong
- St. Louis University
- University of British Columbia
- Papworth Hospital NHS Foundation Trust
- University of Montreal
- University of Alabama, Birmingham
- University of Western Ontario
- Government of France
- Fond de dotation AGIR pour les maladies chroniques
- The University of Texas, Dallas
- Apnimed, Inc.
Organization Involved with Phase 2 Indications (37)
- Actelion
- Eisai
- Sanofi
- Vivus
- Bayer
- American Academy of Otolaryngology-Head and Neck Surgery Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Maastricht University
- University of Arizona
- American Heart Association
- Istituto Auxologico Italiano
- Johns Hopkins University
- Liaoyang Central Hospital
- Monash University
- Northwell Health
- Northwestern University
- University of Southern California
- Mayo Clinic
- Centre de Recherche en Nutrition Humaine Rhone-Alpe
- University of Calgary
- Medical University of South Carolina
- Mid-Atlantic Epilepsy and Sleep Center
- University of Texas at Houston
- State University of New York, Brooklyn
- University of Gothenburg
- University of Wisconsin
- University of Illinois at Chicago
- George Washington University
- Therapix Biosciences Ltd.
- Hektoen Institute for Medical Research
- +7 more
Organization Involved with Phase 1 Indications (15)
- Millennium Pharmaceuticals
- Purdue Pharmaceuticals
- Lakehead University
- New York University
- The New York Eye & Ear Infirmary
- University of Malaya
- West Side ENT
- Columbia University
- Asheville Speech Associates
- Washington University in St. Louis
- Heart and Stroke Foundation of Canada
- Northern Ontario School of Medicine
- Johnson and Johnson
- Idorsia Pharmaceuticals Ltd.
- Michael Smith Foundation for Health Research
Organization Involved with Other Experimental Indications (21)
- Beijing Anzhen Hospital
- Case Western Reserve University
- Guangzhou Medical University
- Kyoto University
- Lund University
- Lovisenberg Diakonale Hospital
- Memorial Hermann Health System
- Stanford University
- University of Iowa
- University of Rochester
- University of Athens
- Virginia Commonwealth University
- Capital Medical University
- Sohag University
- University of California, San Francisco
- Jiao Tong University
- Karolinska Institute
- University of Ostrava
- Health Research Board, Ireland
- National University of Ireland
- Shanghai Stomatological Hospital